TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | -0.47%21.56B | 77.91%30.35B | 146.66%21.66B | -9.77%17.06B | -19.00%8.78B | 115.40%18.91B | 151.02%10.84B | -34.24%8.78B | -65.20%4.32B | -32.90%13.35B |
Profit adjustment | ||||||||||
Investment loss (gain) | 17.07%-34M | 10,927.27%1.21B | -123.70%-41M | 101.70%11M | 135.67%173M | -19.59%-647M | -19.75%-485M | -35.59%-541M | -15.06%-405M | -216.67%-399M |
Attributable subsidiary (profit) loss | -2.72%-1.63B | -2,611.24%-4.58B | -9.25%-1.58B | 94.45%-169M | 12.50%-1.45B | -90.73%-3.05B | -72.86%-1.66B | 32.16%-1.6B | 27.64%-958M | 7.18%-2.35B |
Impairment and provisions: | -25.95%1.21B | 53.95%6.98B | 12.96%1.63B | 733.82%4.54B | 888.52%1.44B | -94.70%544M | -102.56%-183M | 88.78%10.26B | 203.18%7.15B | 28.67%5.44B |
-Other impairments and provisions | -25.95%1.21B | 53.95%6.98B | 12.96%1.63B | 733.82%4.54B | 888.52%1.44B | -94.70%544M | -102.56%-183M | 88.78%10.26B | 203.18%7.15B | 28.67%5.44B |
Asset sale loss (gain): | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---929M |
-Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---929M |
Depreciation and amortization: | 23.76%1.97B | -9.97%3.47B | -16.00%1.59B | -10.17%3.85B | 5.11%1.89B | -18.22%4.29B | -41.78%1.8B | -50.18%5.24B | 103.35%3.1B | 444.18%10.52B |
-Depreciation | 23.76%1.97B | -9.97%3.47B | -16.00%1.59B | -10.17%3.85B | 5.11%1.89B | -18.22%4.29B | -41.78%1.8B | -50.18%5.24B | 103.35%3.1B | 444.18%10.52B |
Exchange Loss (gain) | ---- | -121.92%-10.68B | ---- | 157.26%48.72B | ---- | 173.54%18.94B | ---- | -588.11%-25.75B | ---- | -175.90%-3.74B |
Special items | -42.19%-7.16B | -920.59%-3.82B | -2,779.26%-5.04B | -138.28%-374M | -59.04%188M | 306.55%977M | 187.76%459M | 74.00%-473M | 53.01%-523M | -113.25%-1.82B |
Operating profit before the change of operating capital | -12.66%15.91B | -68.85%22.93B | 65.17%18.22B | 84.27%73.63B | 2.35%11.03B | 1,078.86%39.96B | -15.01%10.78B | -120.35%-4.08B | 0.06%12.68B | -26.96%20.06B |
Change of operating capital | ||||||||||
Loans and payments (increase) decrese | ---- | -144.69%-14.15B | ---- | 387.35%31.65B | ---- | 22.06%-11.01B | ---- | 73.71%-14.13B | ---- | -21.98%-53.76B |
Financial assets at fair value (increase)decrease | ---- | -170.56%-9.99B | ---- | 432.96%14.16B | ---- | -116.82%-4.25B | ---- | 14.99%-1.96B | ---- | -52.34%-2.31B |
Financial liabilities at fair value increase (decrese) | ---- | 173.95%10.1B | ---- | -19.51%-13.65B | ---- | -72.32%-11.43B | ---- | -133.04%-6.63B | ---- | 345.96%20.07B |
Cash from business operations | -12.66%15.91B | -91.60%8.89B | 65.17%18.22B | 697.56%105.79B | 2.35%11.03B | 149.48%13.26B | -15.01%10.78B | -68.14%-26.81B | 0.06%12.68B | -17.01%-15.94B |
Other taxs | -60.10%-2.66B | -48.31%-4.12B | -31.65%-1.66B | 9.78%-2.78B | -26.78%-1.26B | 27.75%-3.08B | 57.99%-997M | -87.87%-4.26B | -76.17%-2.37B | 33.66%-2.27B |
Dividend received - operating | 4.84%130M | 13.03%1.07B | 106.67%124M | 16.83%944M | 500.00%60M | 6.18%808M | -91.67%10M | 20.22%761M | -29.41%120M | -30.44%633M |
Special items of business | -0.91%13.32B | 139.33%33.27B | -58.98%13.45B | -190.66%-84.6B | -34.54%32.78B | -56.09%93.32B | -66.47%50.07B | 349.13%212.52B | 1,128.38%149.36B | -2.73%47.32B |
Net cash from operations | -11.37%26.7B | 102.07%39.11B | -29.30%30.12B | -81.45%19.36B | -28.83%42.61B | -42.75%104.31B | -62.54%59.86B | 512.65%182.22B | 575.54%159.79B | -8.53%29.74B |
Cash flow from investment activities | ||||||||||
Purchase of fixed assets | -41.03%-464M | 10.83%-1.15B | 44.14%-329M | -18.23%-1.28B | -57.07%-589M | 24.90%-1.09B | 16.11%-375M | -7.67%-1.45B | 15.98%-447M | -12.29%-1.34B |
Purchase of intangible assets | 5.79%-1.06B | 18.40%-2.55B | 9.44%-1.12B | -26.06%-3.13B | -22.65%-1.24B | -20.11%-2.48B | -5.64%-1.01B | 9.83%-2.06B | -0.63%-957M | -23.86%-2.29B |
Sale of subsidiaries | -158.71%-721M | ---- | 333.90%1.23B | ---- | -525.00%-525M | ---- | 79.46%-84M | ---- | -445.33%-409M | ---- |
Acquisition of subsidiaries | ---- | 54.20%-453M | ---- | -833.02%-989M | ---- | 82.42%-106M | ---- | -626.51%-603M | ---- | ---83M |
Recovery of cash from investments | -15.31%223.44B | 2.34%504.17B | 6.59%263.84B | -5.48%492.62B | -17.11%247.52B | 9.27%521.19B | 32.28%298.6B | 15.44%476.99B | 10.33%225.73B | 7.03%413.19B |
Cash on investment | 12.81%-260B | -10.26%-563.56B | -12.34%-298.18B | -3.66%-511.1B | -0.85%-265.43B | 0.73%-493.04B | 3.09%-263.2B | -11.38%-496.67B | -15.90%-271.59B | -11.63%-445.91B |
Other items in the investment business | ---- | 117.65%623M | ---- | -215.40%-3.53B | -453.34%-3.76B | 124.60%3.06B | --1.06B | 21.82%1.36B | ---- | 648.04%1.12B |
Net cash from investment operations | -12.24%-38.8B | -129.60%-62.91B | -43.91%-34.57B | -199.51%-27.4B | -168.65%-24.02B | 222.76%27.54B | 173.41%34.99B | 36.49%-22.43B | -52.36%-47.67B | -112.17%-35.32B |
Net cash before financing | -172.22%-12.1B | -195.81%-23.8B | -123.92%-4.45B | -106.10%-8.05B | -80.41%18.59B | -17.49%131.85B | -15.40%94.85B | 2,966.19%159.79B | 1,569.06%112.12B | -135.13%-5.58B |
Cash flow from financing activities | ||||||||||
Refund | -64.06%611M | -44.05%3.09B | -35.80%1.7B | 739.24%5.52B | 410.80%2.65B | 75.58%-864M | 44.60%-852M | 15.96%-3.54B | 62.83%-1.54B | -3.26%-4.21B |
Issuing shares | -44.59%1.11B | --2B | --2B | ---- | ---- | 33.33%2B | --2B | --1.5B | ---- | ---- |
Dividends paid - financing | -68.95%-12.69B | -74.98%-12.2B | -66.96%-7.51B | -9.20%-6.97B | -9.12%-4.5B | -215.52%-6.38B | -242.28%-4.12B | 79.30%-2.02B | 71.81%-1.2B | 9.19%-9.77B |
Issuance expenses and redemption of securities expenses | ---- | -76.65%-4B | -225.03%-2.35B | 34.32%-2.27B | 79.04%-723M | -766.83%-3.45B | -766.83%-3.45B | ---398M | ---398M | ---- |
Other items of the financing business | -177.86%-5.82B | -150.49%-6.45B | 15.48%-2.1B | -22.93%-2.57B | -248,100.00%-2.48B | -1,056.35%-2.09B | 102.08%1M | 78.93%-181M | -277.78%-48M | 53.94%-859M |
Net cash from financing operations | -103.34%-16.79B | -179.32%-17.56B | -63.46%-8.26B | 41.76%-6.29B | 21.38%-5.05B | -132.48%-10.79B | -101.57%-6.43B | 68.72%-4.64B | 61.97%-3.19B | 11.55%-14.84B |
Effect of rate | -252.45%-13.06B | 127.93%10.62B | 121.28%8.57B | -147.83%-38.03B | -735.26%-40.24B | -178.96%-15.35B | 35.37%-4.82B | 1,457.21%19.43B | -4,184.48%-7.46B | 112.61%1.25B |
Net Cash | -127.44%-28.89B | -188.58%-41.36B | -193.87%-12.7B | -111.84%-14.33B | -84.70%13.53B | -21.97%121.05B | -18.82%88.43B | 859.89%155.15B | 780.22%108.93B | -2,138.71%-20.42B |
Begining period cash | -5.89%490.93B | -9.12%521.67B | -9.12%521.67B | 22.57%574.03B | 22.57%574.03B | 59.43%468.32B | 59.43%468.32B | -6.13%293.74B | -6.13%293.74B | -3.34%312.91B |
Cash at the end | -13.25%448.98B | -5.89%490.93B | -5.44%517.53B | -9.12%521.67B | -0.84%547.32B | 22.57%574.03B | 39.65%551.93B | 59.43%468.32B | 33.19%395.22B | -6.13%293.74B |
Cash balance analysis | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | PricewaterhouseCoopers LLP | -- | PricewaterhouseCoopers LLP | -- | PricewaterhouseCoopers LLP | -- | PricewaterhouseCoopers LLP | -- | PricewaterhouseCoopers LLP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.